An observational study in Glaucoma and Retinal Pathology, sponsored by Mid-Atlantic Glaucoma Experts. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-04-26.
Sponsored by Mid-Atlantic Glaucoma Experts · Observational
The investigators are interested in seeing how people with low vision (decreased visual acuity or restricted visual fields) instill eye drops into their own eyes. The investigators hypothesis is that this population will have more difficulty with self-instillation of drops than a better-seeing population. The investigators aim to explore whatever factors may be involved in preventing this population from getting prescribed eyedrops into their eyes, whether it is more related to visual field or visual acuity.
This is a study that involves a questionnaire that a study participant fills out, detailing their experience with eyedrops (if any), followed by a video recording of them instilling artificial tears into their worse-seeing eye, with their dominant hand. Patients must have visual acuity worse than 20/60 in at least one eye, and/or have a recent visual field that demonstrated Hodapp criteria for Moderate or Severe visual field damage. This is an observational study of how patients with low vision due to either glaucoma or retinal disease instill eyedrops. Each video will be "graded" by the principal investigator for "success" at instilling eyedrops, and patients will be stratified by their visual acuity or visual field, and whether they have a primary diagnosis of glaucoma or retinal disease.
1,818 studies on the registry are indexed under Glaucoma; 231 are open to participants now.
This study's planned enrollment of 200 is above the median of 103 across 454 observational studies indexed under Glaucoma.
Browse Glaucoma studies →This is the only study on the registry with Mid-Atlantic Glaucoma Experts as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Patients reporting for appointments at outpatients referral practices shared by 2 glaucoma and 3 retina specialists
Exclusion Criteria:
This is a group of patients with restricted visual fields or ETDRS visual acuity of 20/60 or worse
A group of patients with retinal pathology(ARMD, CME, diabetic retinopathy) contributing to their decreased vision.
Successful instillation of a single eyedrop onto the surface of the eye
Time frame: 2 minutes
This study is completed, as verified in Apr 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.